A citation-based method for searching scientific literature

John W Eikelboom, Stuart J Connolly, Martina Brueckmann, Christopher B Granger, Arie P Kappetein, Michael J Mack, Jon Blatchford, Kevin Devenny, Jeffrey Friedman, Kelly Guiver, Ruth Harper, Yasser Khder, Maximilian T Lobmeyer, Hugo Maas, Jens-Uwe Voigt, Maarten L Simoons, Frans Van de Werf. N Engl J Med 2013
Times Cited: 818







List of co-cited articles
2052 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dabigatran versus warfarin in patients with atrial fibrillation.
Stuart J Connolly, Michael D Ezekowitz, Salim Yusuf, John Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul A Reilly, Ellison Themeles, Jeanne Varrone,[...]. N Engl J Med 2009
35

Edoxaban versus warfarin in patients with atrial fibrillation.
Robert P Giugliano, Christian T Ruff, Eugene Braunwald, Sabina A Murphy, Stephen D Wiviott, Jonathan L Halperin, Albert L Waldo, Michael D Ezekowitz, Jeffrey I Weitz, Jindřich Špinar,[...]. N Engl J Med 2013
30

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Manesh R Patel, Kenneth W Mahaffey, Jyotsna Garg, Guohua Pan, Daniel E Singer, Werner Hacke, Günter Breithardt, Jonathan L Halperin, Graeme J Hankey, Jonathan P Piccini,[...]. N Engl J Med 2011
30

Apixaban versus warfarin in patients with atrial fibrillation.
Christopher B Granger, John H Alexander, John J V McMurray, Renato D Lopes, Elaine M Hylek, Michael Hanna, Hussein R Al-Khalidi, Jack Ansell, Dan Atar, Alvaro Avezum,[...]. N Engl J Med 2011
29

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Christian T Ruff, Robert P Giugliano, Eugene Braunwald, Elaine B Hoffman, Naveen Deenadayalu, Michael D Ezekowitz, A John Camm, Jeffrey I Weitz, Basil S Lewis, Alexander Parkhomenko,[...]. Lancet 2014
21

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
George D Dangas, Jan G P Tijssen, Jochen Wöhrle, Lars Søndergaard, Martine Gilard, Helge Möllmann, Raj R Makkar, Howard C Herrmann, Gennaro Giustino, Stephan Baldus,[...]. N Engl J Med 2020
177
20

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
C Michael Gibson, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W Verheugt, Peter Wildgoose, Mary Birmingham, Juliana Ianus, Paul Burton, Martin van Eickels,[...]. N Engl J Med 2016
870
19

2017 ESC/EACTS Guidelines for the management of valvular heart disease.
Helmut Baumgartner, Volkmar Falk, Jeroen J Bax, Michele De Bonis, Christian Hamm, Per Johan Holm, Bernard Iung, Patrizio Lancellotti, Emmanuel Lansac, Daniel Rodriguez Muñoz,[...]. Eur Heart J 2017
17

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
Pascal Vranckx, Marco Valgimigli, Lars Eckardt, Jan Tijssen, Thorsten Lewalter, Giuseppe Gargiulo, Valerii Batushkin, Gianluca Campo, Zoreslava Lysak, Igor Vakaliuk,[...]. Lancet 2019
285
17


Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
Helio P Guimarães, Renato D Lopes, Pedro G M de Barros E Silva, Idelzuita L Liporace, Roney O Sampaio, Flávio Tarasoutchi, Conrado R Hoffmann-Filho, Rodrigo de Lemos Soares Patriota, Tiago L L Leiria, Diana Lamprea,[...]. N Engl J Med 2020
69
24

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks,[...]. Eur Heart J 2016
16

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Christopher P Cannon, Deepak L Bhatt, Jonas Oldgren, Gregory Y H Lip, Stephen G Ellis, Takeshi Kimura, Michael Maeng, Bela Merkely, Uwe Zeymer, Savion Gropper,[...]. N Engl J Med 2017
735
16

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
Renato D Lopes, Gretchen Heizer, Ronald Aronson, Amit N Vora, Tyler Massaro, Roxana Mehran, Shaun G Goodman, Stephan Windecker, Harald Darius, Jia Li,[...]. N Engl J Med 2019
486
16

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Jan Steffel, Peter Verhamme, Tatjana S Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling,[...]. Eur Heart J 2018
943
15


Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
Ju Youn Kim, Sung-Hwan Kim, Jun-Pyo Myong, Yoo Ri Kim, Tae-Seok Kim, Ji-Hoon Kim, Sung-Won Jang, Yong-Seog Oh, Man Young Lee, Tai-Ho Rho. J Am Coll Cardiol 2019
36
38

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.
Charles V Pollack, Paul A Reilly, Joanne van Ryn, John W Eikelboom, Stephan Glund, Richard A Bernstein, Robert Dubiel, Menno V Huisman, Elaine M Hylek, Chak-Wah Kam,[...]. N Engl J Med 2017
506
13

Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.
Anthony P Carnicelli, Raffaele De Caterina, Jonathan L Halperin, Giulia Renda, Christian T Ruff, Marco Trevisan, Francesco Nordio, Michele F Mercuri, Elliott Antman, Robert P Giugliano. Circulation 2017
89
13

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.
Konstantinos C Siontis, Xiaosong Zhang, Ashley Eckard, Nicole Bhave, Douglas E Schaubel, Kevin He, Anca Tilea, Austin G Stack, Rajesh Balkrishnan, Xiaoxi Yao,[...]. Circulation 2018
205
11

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial.
Günter Breithardt, Helmut Baumgartner, Scott D Berkowitz, Anne S Hellkamp, Jonathan P Piccini, Susanna R Stevens, Yuliya Lokhnygina, Manesh R Patel, Jonathan L Halperin, Daniel E Singer,[...]. Eur Heart J 2014
119
11




Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Junya Ako, Tetsuya Matoba, Masato Nakamura, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama,[...]. N Engl J Med 2019
170
10

Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement.
David Jochheim, Marco Barbanti, Giuliana Capretti, Giulio G Stefanini, Alexander Hapfelmeier, Magda Zadrozny, Moritz Baquet, Julius Fischer, Hans Theiss, Denise Todaro,[...]. JACC Cardiovasc Interv 2019
43
23

Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi.
Austin A Robinson, Cory R Trankle, Grayson Eubanks, Christopher Schumann, Paul Thompson, Ryan L Wallace, Shouri Gottiparthi, Benjamin Ruth, Christopher M Kramer, Michael Salerno,[...]. JAMA Cardiol 2020
78
12


Oral apixaban for the treatment of acute venous thromboembolism.
Giancarlo Agnelli, Harry R Buller, Alexander Cohen, Madelyn Curto, Alexander S Gallus, Margot Johnson, Urszula Masiukiewicz, Raphael Pak, John Thompson, Gary E Raskob,[...]. N Engl J Med 2013
10

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Walter N Kernan, Bruce Ovbiagele, Henry R Black, Dawn M Bravata, Marc I Chimowitz, Michael D Ezekowitz, Margaret C Fang, Marc Fisher, Karen L Furie, Donald V Heck,[...]. Stroke 2014
10

Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Alvaro Avezum, Renato D Lopes, Phillip J Schulte, Fernando Lanas, Bernard J Gersh, Michael Hanna, Prem Pais, Cetin Erol, Rafael Diaz, M Cecilia Bahit,[...]. Circulation 2015
144
10

Prosthetic Heart Valve Thrombosis.
George D Dangas, Jeffrey I Weitz, Gennaro Giustino, Raj Makkar, Roxana Mehran. J Am Coll Cardiol 2016
172
10

Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement.
Julia Seeger, Birgid Gonska, Christoph Rodewald, Wolfgang Rottbauer, Jochen Wöhrle. JACC Cardiovasc Interv 2017
74
12

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Rick A Nishimura, Catherine M Otto, Robert O Bonow, Blase A Carabello, John P Erwin, Lee A Fleisher, Hani Jneid, Michael J Mack, Christopher J McLeod, Patrick T O'Gara,[...]. J Am Coll Cardiol 2017
9

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Craig T January, L Samuel Wann, Hugh Calkins, Lin Y Chen, Joaquin E Cigarroa, Joseph C Cleveland, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field, Karen L Furie,[...]. J Am Coll Cardiol 2019
763
9

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Rick A Nishimura, Catherine M Otto, Robert O Bonow, Blase A Carabello, John P Erwin, Lee A Fleisher, Hani Jneid, Michael J Mack, Christopher J McLeod, Patrick T O'Gara,[...]. Circulation 2017
9


Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Vittorio Pengo, Gentian Denas, Giacomo Zoppellaro, Seena Padayattil Jose, Ariela Hoxha, Amelia Ruffatti, Laura Andreoli, Angela Tincani, Caterina Cenci, Domenico Prisco,[...]. Blood 2018
299
9

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
John W Eikelboom, Stuart J Connolly, Jackie Bosch, Gilles R Dagenais, Robert G Hart, Olga Shestakovska, Rafael Diaz, Marco Alings, Eva M Lonn, Sonia S Anand,[...]. N Engl J Med 2017
9

Oral rivaroxaban for symptomatic venous thromboembolism.
Rupert Bauersachs, Scott D Berkowitz, Benjamin Brenner, Harry R Buller, Hervé Decousus, Alex S Gallus, Anthonie W Lensing, Frank Misselwitz, Martin H Prins, Gary E Raskob,[...]. N Engl J Med 2010
9

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding.
Charlotte Mérie, Lars Køber, Peter Skov Olsen, Charlotte Andersson, Gunnar Gislason, Jan Skov Jensen, Christian Torp-Pedersen. JAMA 2012
146
9

Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
Tarun Chakravarty, Lars Søndergaard, John Friedman, Ole De Backer, Daniel Berman, Klaus F Kofoed, Hasan Jilaihawi, Takahiro Shiota, Yigal Abramowitz, Troels H Jørgensen,[...]. Lancet 2017
469
9

Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.
John Puskas, Marc Gerdisch, Dennis Nichols, Reed Quinn, Charles Anderson, Birger Rhenman, Lilibeth Fermin, Michael McGrath, Bobby Kong, Chad Hughes,[...]. J Thorac Cardiovasc Surg 2014
147
9

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
Stuart J Connolly, Mark Crowther, John W Eikelboom, C Michael Gibson, John T Curnutte, John H Lawrence, Patrick Yue, Michele D Bronson, Genmin Lu, Pamela B Conley,[...]. N Engl J Med 2019
354
8

Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study.
André Rodrigues Durães, Pollianna de Souza Roriz, Bianca de Almeida Nunes, Felipe Pinho E Albuquerque, Fábio Vieira de Bulhões, Andre Mauricio de Souza Fernandes, Roque Aras. Drugs R D 2016
51
15

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.
David R Holmes, Vivek Y Reddy, Zoltan G Turi, Shephal K Doshi, Horst Sievert, Maurice Buchbinder, Christopher M Mullin, Peter Sick. Lancet 2009
8

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
Hugh Calkins, Stephan Willems, Edward P Gerstenfeld, Atul Verma, Richard Schilling, Stefan H Hohnloser, Ken Okumura, Harvey Serota, Matias Nordaby, Kelly Guiver,[...]. N Engl J Med 2017
249
8

Dabigatran versus warfarin in the treatment of acute venous thromboembolism.
Sam Schulman, Clive Kearon, Ajay K Kakkar, Patrick Mismetti, Sebastian Schellong, Henry Eriksson, David Baanstra, Janet Schnee, Samuel Z Goldhaber. N Engl J Med 2009
8

Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Harry R Büller, Claudette Bethune, Sanjay Bhanot, David Gailani, Brett P Monia, Gary E Raskob, Annelise Segers, Peter Verhamme, Jeffrey I Weitz. N Engl J Med 2015
330
8

Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy).
Michael D Ezekowitz, Rangadham Nagarakanti, Herbert Noack, Martina Brueckmann, Claire Litherland, Mark Jacobs, Andreas Clemens, Paul A Reilly, Stuart J Connolly, Salim Yusuf,[...]. Circulation 2016
94
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.